Gianotti N, et al. - This work was planned to assess the durability of switch regimens based on rilpivirine or on integrase inhibitors, both in association with tenofovir and emtricitabine, in HIV-infected, virologically suppressed patients. As per findings, the two regimens were comparable regarding the durability and had a very low probability of virological failure.